ArticleMedComm2024

Synthetic self-adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy.

Yang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.